Valtrex (valacyclovir) is now approved to decrease heterosexual transmission of genital herpes

October 2003

Valtrex (valacyclovir) is now approved to decrease heterosexual transmission of genital herpes.

Using Valtrex with a condom can reduce transmission by about 50%...compared to a condom alone.

Some patients already take Valtrex daily to reduce outbreaks. Now some patients will use it to reduce the risk of giving herpes to their partner.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Metabolic syndrome
confusion between Wellbutrin SR and the new Wellbutrin XL
using antidepressants in children and teens might not work...or might increase suicide risk
Infectious Diseases Valtrex (valacyclovir) is now approved to decrease heterosexual transmission of genital herpes
Cardiology interest in Aceon and other ACE inhibitors for patients with coronary heart disease
Cardiology statins for peripheral arterial disease
Rheumatology You might see more cases of gout
Heart Failure angiotensin receptor blocker (ARB) for heart failure
Diabetes interaction between gemfibrozil and Avandia
Women's Health Seasonale, a new extended-cycle oral contraceptive
Women's Health "bioidentical" hormone therapy
Pregnancy NSAIDs might increase the risk of miscarriage
Vaccines Flu vaccine will be plentiful this year
Vaccines Is the varicella vaccine less effective in kids with asthma
Is it okay for patients with hypertension to take pseudoephedrine (Sudafed, etc)
Practice California will finally accept NAPLEX